Tango Therapeutics Executive Chair Barbara Weber Steps Down

GlobeNewswire·6 Aug 2026·Read original

2▲0 ▼0Impact / 5

Summary · why it matters

Tango Therapeutics announced that Executive Chairman Dr. Barbara Weber is stepping down from the board to pursue other interests. The clinical-stage precision cancer medicine company expressed gratitude for her vision and leadership. No successor was named in the announcement.

Tango Therapeutics Inc ±

Impact on assets 1

Biotech & Genomic Medicine▲ · 1 stocks

Tango Therapeutics Inc

TNGX

± Mixedrelevance

Executive chair departure without successor creates leadership uncertainty.

Tango Therapeutics Executive Chair Barbara Weber Steps Down

Impact on assets 1

Theme Impact

Off-coverage companies

Related news